Importance of the Lipid Layer in Human Tear Film Stability and Evaporation
Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film...
Saved in:
Published in | Optometry and vision science Vol. 74; no. 1; pp. 8 - 13 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
01.01.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals.
The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment.
Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability.
Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded. |
---|---|
AbstractList | Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals.PURPOSEPrevious work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals.The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment.METHODSThe left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment.Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability.RESULTSTear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability.Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded.CONCLUSIONSWhere the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded. Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals. The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment. Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability. Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded. Purpose. Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested that the lipid layer does not play a role in retarding evaporation of the aqueous layer. The importance of the lipid layer in human tear film stability and evaporation was determined in the current study by measurement of these parameters in the same individuals. Methods. The left eyes of 161 normal and dry eye subjects (72 males, 89 females), with an age range of 13 to 85 years, were examined. Tear evaporation was derived from the vapor pressure gradient measured with a modified Servomed evaporimeter. Lipid layer structure and noninvasive break-up time (NIBUT) were assessed clinically, by specular reflection, with the Keeler Tearscope. Lipid layer structure was categorized into marmoreal (open and closed meshwork), flow, amorphous, and colored fringe (normal and abnormal) patterns. These observed patterns reflect lipid layer thickness. Ambient temperature and relative humidity remained fairly constant throughout the experiment. Results. Tear evaporation rate was found to vary significantly with different lipid layer patterns. Eyes with no visible lipid layer, or exhibiting an abnormal colored fringe pattern (with clumping of lipid amidst areas of little or no lipid cover), demonstrated a significantly higher rate of evaporation of the tear film (p < 0.001). There were no significant differences amongst the remainder of the patterns. The NIBUT was also found to vary significantly with lipid layer pattern (p < 0.001), with the absent or abnormal colored fringe lipid patterns exhibiting the poorest stability. Conclusions. Where the human lipid layer is absent, or is not confluent, and the tear film is unstable, tear evaporation is increased four-fold. However, where there is a stable, intact lipid layer, regardless of lipid thickness, tear evaporation is retarded. |
Author | TOMLINSON, ALAN CRAIG, JENNIFER P. |
Author_xml | – sequence: 1 givenname: JENNIFER P. surname: CRAIG fullname: CRAIG, JENNIFER P. – sequence: 2 givenname: ALAN surname: TOMLINSON fullname: TOMLINSON, ALAN |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2613866$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9148269$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkTtPwzAUhT0UlVL4CUgeEFvAThw_FiRUtbSoEgNljm4SRxjlUWwHqf8etw0dWGrJsnzvd85wzhUatV2rEcKUPFCixCMJhycxi6hSgtDwi8KlbIQmlDASpUzKS3Tl3FeYiiTlYzRWlMmYqwl6XTXbznpoC427CvtPjddma0q8hp222LR42TfQ4o0GixembvC7h9zUxu8wtCWe_0DQgzdde40uKqidvhneKfpYzDezZbR-e1nNntdRwRLuI0iFTlmec6GFZKLSMaOylKrKc5HSMqa0EFKVoopFyZSGRCQECOMUwjBRVTJF90ffre2-e-181hhX6LqGVne9y4SUkgiengUpJ0SImAfwdgD7vNFltrWmAbvLhpTC_m7YgyugrmyIy7gTFnOaSL63kUessJ1zVlcngpJsX1X2V1V2qio7VBWkT_-khfGHVL0FU583-AV7SZiF |
CODEN | OVSCET |
CitedBy_id | crossref_primary_10_1016_j_clae_2010_02_003 crossref_primary_10_1080_02713680902972366 crossref_primary_10_1016_j_clae_2005_06_001 crossref_primary_10_1016_j_optom_2018_01_004 crossref_primary_10_1016_j_clae_2009_06_004 crossref_primary_10_1111_cxo_12546 crossref_primary_10_1136_bjophthalmol_2019_315747 crossref_primary_10_1016_j_pquantelec_2018_10_001 crossref_primary_10_1111_ceo_12135 crossref_primary_10_1097_OPX_0b013e318253de93 crossref_primary_10_1016_S1542_0124_12_70262_8 crossref_primary_10_1039_C6LC01450J crossref_primary_10_1097_OPX_0b013e318181ae60 crossref_primary_10_1016_j_exer_2013_08_010 crossref_primary_10_4103_IJO_IJO_2851_22 crossref_primary_10_1155_2019_8127515 crossref_primary_10_1007_s10792_020_01300_z crossref_primary_10_1097_ICO_0000000000000092 crossref_primary_10_1097_ICO_0000000000001181 crossref_primary_10_1016_j_clae_2022_101705 crossref_primary_10_1080_02713683_2022_2093381 crossref_primary_10_1007_s00417_015_3080_5 crossref_primary_10_1016_j_preteyeres_2004_04_003 crossref_primary_10_1371_journal_pone_0092461 crossref_primary_10_1097_01_ICL_0000141921_80061_17 crossref_primary_10_12968_opti_2016_2_109 crossref_primary_10_1016_j_clae_2014_09_007 crossref_primary_10_1016_j_jtos_2019_11_004 crossref_primary_10_1016_j_oftal_2022_03_008 crossref_primary_10_1016_S1542_0124_12_70081_2 crossref_primary_10_1097_OPX_0b013e3181d951df crossref_primary_10_1097_00006324_200206000_00009 crossref_primary_10_3390_diagnostics10080511 crossref_primary_10_1016_j_clae_2017_12_003 crossref_primary_10_1097_ICO_0000000000000660 crossref_primary_10_15406_aovs_2015_02_00038 crossref_primary_10_1016_j_jtos_2018_09_005 crossref_primary_10_1016_j_tvjl_2006_10_008 crossref_primary_10_1016_j_clae_2017_07_003 crossref_primary_10_1007_s00417_006_0452_x crossref_primary_10_1146_annurev_fluid_120710_101042 crossref_primary_10_1016_j_clim_2017_04_017 crossref_primary_10_1097_ICL_0b013e3181a9d79d crossref_primary_10_1097_ICL_0000000000000103 crossref_primary_10_1111_aos_12012 crossref_primary_10_1016_j_clae_2021_02_009 crossref_primary_10_1167_iovs_64_1_13 crossref_primary_10_1002_bip_20798 crossref_primary_10_1016_j_jtos_2014_01_004 crossref_primary_10_1016_j_clae_2021_01_004 crossref_primary_10_1210_jcem_85_12_7066 crossref_primary_10_1007_s11538_012_9746_9 crossref_primary_10_3109_02713683_2010_490895 crossref_primary_10_1002_jbm_b_32927 crossref_primary_10_1016_j_exer_2013_05_010 crossref_primary_10_1016_S0161_6420_03_00451_2 crossref_primary_10_1080_17469899_2023_2258279 crossref_primary_10_3341_jkos_2020_61_1_1 crossref_primary_10_3390_ijms232314947 crossref_primary_10_1016_S0014_4835_03_00199_4 crossref_primary_10_1111_j_1444_0938_2011_00634_x crossref_primary_10_1097_OPX_0000000000001680 crossref_primary_10_1016_j_jtos_2021_04_006 crossref_primary_10_1097_01_ico_0000148291_38076_59 crossref_primary_10_1046_j_1475_1313_2002_00042_x crossref_primary_10_1016_j_jtos_2019_03_004 crossref_primary_10_1080_09273948_2019_1571212 crossref_primary_10_1016_j_clae_2012_05_003 crossref_primary_10_1097_ICL_0b013e31828af164 crossref_primary_10_18621_eurj_558779 crossref_primary_10_1097_01_icl_0000240501_07041_f8 crossref_primary_10_1016_S1367_0484_00_80024_7 crossref_primary_10_1097_ICO_0b013e31824d0d04 crossref_primary_10_1097_00003226_200308000_00006 crossref_primary_10_1007_s00717_020_00475_1 crossref_primary_10_1021_acs_langmuir_9b01114 crossref_primary_10_1111_j_1444_0938_2007_00136_x crossref_primary_10_1016_j_clae_2017_01_004 crossref_primary_10_1016_j_jtos_2021_10_009 crossref_primary_10_1136_bmjophth_2020_000697 crossref_primary_10_1016_j_oftale_2022_03_015 crossref_primary_10_1118_1_3495540 crossref_primary_10_3390_medicina60091458 crossref_primary_10_1097_ICO_0b013e31802b492d crossref_primary_10_1097_OPX_0b013e31826f32e0 crossref_primary_10_1016_j_aanat_2015_07_007 crossref_primary_10_1097_OPX_0b013e3181c07908 crossref_primary_10_1155_2015_704946 crossref_primary_10_1155_2016_7285132 crossref_primary_10_1016_j_jprot_2012_11_017 crossref_primary_10_1016_S1367_0484_98_80035_0 crossref_primary_10_1155_2016_5728071 crossref_primary_10_1097_01_opx_0000236810_17338_cf crossref_primary_10_1080_02713683_2018_1554154 crossref_primary_10_1016_j_jtos_2020_12_006 crossref_primary_10_1016_j_clae_2003_09_002 crossref_primary_10_1080_02713683_2018_1433860 crossref_primary_10_1016_j_clae_2019_08_003 crossref_primary_10_18231_j_ijceo_2020_023 crossref_primary_10_2147_OPTO_S262353 crossref_primary_10_1016_j_jtos_2013_04_004 crossref_primary_10_1016_S1542_0124_11_70009_X crossref_primary_10_1186_s12938_018_0597_y crossref_primary_10_1016_j_chemphyslip_2007_04_001 crossref_primary_10_1016_j_envint_2008_04_005 crossref_primary_10_1021_acs_joc_0c02882 crossref_primary_10_1038_s41598_020_71259_5 crossref_primary_10_1076_ceyr_25_4_227_13482 crossref_primary_10_1016_j_clae_2019_11_009 crossref_primary_10_1364_OL_44_002410 crossref_primary_10_1021_acs_langmuir_8b04182 crossref_primary_10_1016_j_colsurfb_2019_04_051 crossref_primary_10_1016_j_clae_2010_03_002 crossref_primary_10_1016_j_optom_2019_09_002 crossref_primary_10_1016_j_apm_2014_05_006 crossref_primary_10_1021_la501678t crossref_primary_10_1111_opo_13308 crossref_primary_10_1016_j_clae_2022_101736 crossref_primary_10_1155_2014_848659 crossref_primary_10_1097_ICL_0000000000000788 crossref_primary_10_18231_j_ijceo_2020_030 crossref_primary_10_1097_01_opx_0000171818_01353_8c crossref_primary_10_1016_j_clae_2015_06_002 crossref_primary_10_5301_ejo_5000277 crossref_primary_10_1016_j_clinthera_2015_01_001 crossref_primary_10_1016_S0181_5512_06_73800_1 crossref_primary_10_1080_02713683_2017_1418894 crossref_primary_10_1097_OPX_0000000000000827 crossref_primary_10_1097_ICO_0000000000002133 crossref_primary_10_19161_etd_416656 crossref_primary_10_1016_j_clae_2021_101560 crossref_primary_10_3390_ijms24086983 crossref_primary_10_3928_1081_597X_20010101_02 crossref_primary_10_1016_j_jfo_2018_10_004 crossref_primary_10_1016_j_exer_2022_109061 crossref_primary_10_3390_pharmaceutics13020207 crossref_primary_10_1097_OPX_0b013e318181ae02 crossref_primary_10_1017_jfm_2018_776 crossref_primary_10_1016_j_clae_2019_04_003 crossref_primary_10_1016_S1542_0124_12_70186_6 crossref_primary_10_1016_j_clae_2009_12_007 crossref_primary_10_1172_jci_insight_151078 crossref_primary_10_3390_medicina59101862 crossref_primary_10_1097_ICO_0b013e3181ba0cb2 crossref_primary_10_1167_iovs_18_26390 crossref_primary_10_2174_2210681213666230526152322 crossref_primary_10_1016_j_clae_2014_05_008 crossref_primary_10_1016_j_exer_2009_11_013 crossref_primary_10_1038_s41598_021_94568_9 crossref_primary_10_12677_HJO_2023_121008 crossref_primary_10_1097_00006324_200002000_00010 crossref_primary_10_3390_jcm13051220 crossref_primary_10_1016_j_jtos_2020_01_003 crossref_primary_10_1016_j_preteyeres_2021_101012 crossref_primary_10_2147_OPTH_S270575 crossref_primary_10_1007_s00417_020_05044_5 crossref_primary_10_1016_j_clae_2013_02_009 crossref_primary_10_1016_j_jtos_2022_01_002 crossref_primary_10_1080_01647954_2021_1919757 crossref_primary_10_1016_j_jfo_2018_08_017 crossref_primary_10_1016_j_jtos_2012_07_004 crossref_primary_10_1016_j_biopha_2025_117937 crossref_primary_10_1016_j_jtos_2017_05_006 crossref_primary_10_1007_s40123_022_00518_7 crossref_primary_10_1080_02713683_2018_1437454 crossref_primary_10_17116_oftalma202313903281 crossref_primary_10_1016_j_jtos_2017_05_001 crossref_primary_10_1016_j_clae_2019_09_004 crossref_primary_10_1016_j_jtos_2021_03_006 crossref_primary_10_1016_S1542_0124_11_70033_7 crossref_primary_10_3341_kjo_2019_0133 crossref_primary_10_3928_1081597X_20200519_01 crossref_primary_10_1097_ICL_0000000000000073 crossref_primary_10_1529_biophysj_105_078592 crossref_primary_10_1167_tvst_8_5_1 crossref_primary_10_1089_jop_2017_0052 crossref_primary_10_1097_ICL_0b013e31822e8df2 crossref_primary_10_3390_ijms18071398 crossref_primary_10_1097_OPX_0b013e3181bc63cc crossref_primary_10_1016_j_jtos_2016_03_002 crossref_primary_10_1016_j_jtos_2018_03_002 crossref_primary_10_3389_ftox_2023_1173683 crossref_primary_10_1016_j_clae_2025_102369 crossref_primary_10_1097_00006324_200403000_00012 crossref_primary_10_1007_s11538_006_9105_9 crossref_primary_10_1371_journal_pone_0109843 crossref_primary_10_1016_j_jtos_2017_05_011 crossref_primary_10_1097_ICO_0b013e318191b870 crossref_primary_10_1016_j_exer_2021_108567 crossref_primary_10_1088_1742_6596_1073_6_062034 crossref_primary_10_1021_acs_jpclett_9b01187 crossref_primary_10_3390_jcm12206631 crossref_primary_10_3389_fmed_2021_781382 crossref_primary_10_3390_colloids5020030 crossref_primary_10_1186_s12917_019_2203_3 crossref_primary_10_26599_FRICT_2025_9441014 crossref_primary_10_1016_j_addr_2023_115004 crossref_primary_10_1097_OPX_0000000000000601 crossref_primary_10_3390_diagnostics10090711 crossref_primary_10_1007_s11538_018_0517_0 crossref_primary_10_5005_hoo_10101_39402 crossref_primary_10_1016_j_ajo_2007_04_006 crossref_primary_10_1097_OPX_0000000000001136 crossref_primary_10_3109_02713683_2011_574331 crossref_primary_10_1016_j_exer_2012_04_003 crossref_primary_10_1097_OPX_0000000000002225 crossref_primary_10_1038_sj_eye_6700224 crossref_primary_10_1097_ICO_0b013e31826671ab crossref_primary_10_3390_diagnostics12061431 crossref_primary_10_1097_OPX_0b013e318253dea9 crossref_primary_10_1016_j_cis_2013_03_007 crossref_primary_10_1016_j_exer_2010_05_014 crossref_primary_10_1186_s12886_018_0700_y crossref_primary_10_3341_jkos_2016_57_12_1857 crossref_primary_10_1080_08820538_2020_1755321 crossref_primary_10_1016_j_ajo_2013_01_008 crossref_primary_10_1016_j_preteyeres_2014_11_001 crossref_primary_10_1016_j_exer_2017_03_013 crossref_primary_10_1097_ICO_0000000000000393 crossref_primary_10_1016_j_addr_2017_09_023 crossref_primary_10_1080_02713680490516099 crossref_primary_10_1111_j_1469_7580_2005_00386_x crossref_primary_10_1167_iovs_17_23700 crossref_primary_10_1080_14656566_2025_2450360 crossref_primary_10_2147_OPTH_S322461 crossref_primary_10_1016_j_jtos_2023_07_002 crossref_primary_10_1016_j_jtos_2023_07_004 crossref_primary_10_1016_j_bbamem_2014_05_007 crossref_primary_10_1016_j_actbio_2021_05_051 crossref_primary_10_1016_S1542_0124_12_70086_1 crossref_primary_10_1111_j_1749_6632_2002_tb04217_x crossref_primary_10_1016_j_clae_2018_12_002 crossref_primary_10_1016_j_clae_2017_09_004 crossref_primary_10_1364_OSAC_1_001041 crossref_primary_10_1016_j_ajo_2013_01_017 crossref_primary_10_1016_j_clae_2007_12_001 crossref_primary_10_1016_j_exer_2023_109557 crossref_primary_10_1016_j_exer_2017_03_006 crossref_primary_10_1097_ICO_0000000000001377 crossref_primary_10_1097_OPX_0000000000000749 crossref_primary_10_1016_j_cis_2015_12_009 crossref_primary_10_1016_j_clae_2017_09_013 crossref_primary_10_1016_S1542_0124_12_70233_1 crossref_primary_10_1021_bm100655j crossref_primary_10_1097_OPX_0000000000000866 crossref_primary_10_1097_OPX_0000000000001156 crossref_primary_10_1016_j_clae_2016_11_002 crossref_primary_10_1016_S1542_0124_12_70150_7 crossref_primary_10_1016_j_jtos_2021_10_003 crossref_primary_10_1097_OPX_0000000000002000 crossref_primary_10_1016_j_jtos_2014_06_002 crossref_primary_10_1016_j_jtos_2018_06_001 crossref_primary_10_1016_j_ajo_2022_02_010 crossref_primary_10_1016_j_jtos_2021_12_011 crossref_primary_10_1016_j_optom_2012_10_001 crossref_primary_10_1371_journal_pone_0270810 crossref_primary_10_1016_S1542_0124_12_70095_2 crossref_primary_10_1136_bmjophth_2020_000614 crossref_primary_10_1097_ICO_0b013e318197ec24 crossref_primary_10_1111_vop_12033 crossref_primary_10_1016_S0181_5512_07_89584_2 crossref_primary_10_1016_j_exer_2006_02_002 crossref_primary_10_1097_ICL_0b013e318193f4fc crossref_primary_10_1002_14651858_CD009729_pub2 crossref_primary_10_1016_j_bbamem_2016_02_020 crossref_primary_10_1016_j_clae_2024_102154 crossref_primary_10_1097_ICO_0000000000000452 crossref_primary_10_1016_S1542_0124_12_70299_9 crossref_primary_10_1016_j_cis_2013_06_001 crossref_primary_10_1016_j_jtos_2018_12_003 crossref_primary_10_1097_ICL_0b013e31818c5d00 crossref_primary_10_1016_j_ajo_2006_03_022 crossref_primary_10_1016_j_jtos_2012_08_001 crossref_primary_10_1038_s41598_017_17536_2 crossref_primary_10_1097_OPX_0000000000000098 crossref_primary_10_1097_01_ico_0000247219_18295_5e crossref_primary_10_1016_j_clae_2020_04_003 crossref_primary_10_1016_j_pain_2014_04_025 crossref_primary_10_1117_1_2209881 crossref_primary_10_1016_j_jcis_2022_06_032 crossref_primary_10_1111_cxo_12597 crossref_primary_10_1021_acsbiomaterials_2c00182 crossref_primary_10_7717_peerj_18258 crossref_primary_10_1006_clim_2001_5128 crossref_primary_10_1016_j_clae_2020_03_014 crossref_primary_10_1016_j_jtos_2014_02_002 crossref_primary_10_1080_09273948_2021_1905856 crossref_primary_10_1097_OPX_0b013e3181d951b2 crossref_primary_10_1007_s00417_021_05162_8 crossref_primary_10_1016_j_clae_2019_06_004 crossref_primary_10_1016_j_clae_2019_06_001 crossref_primary_10_1097_OPX_0000000000001852 crossref_primary_10_1016_j_jtos_2019_06_003 crossref_primary_10_1371_journal_pone_0135629 crossref_primary_10_1097_01_icl_0000247638_50568_c0 crossref_primary_10_1016_j_procs_2016_05_296 crossref_primary_10_1021_ie5030497 crossref_primary_10_1016_j_clae_2014_07_006 crossref_primary_10_53730_ijhs_v8nS1_15117 crossref_primary_10_1016_j_clae_2024_102257 crossref_primary_10_1016_j_preteyeres_2017_02_002 crossref_primary_10_1016_j_clae_2019_07_008 crossref_primary_10_1016_j_exer_2014_01_007 crossref_primary_10_1167_tvst_10_14_6 crossref_primary_10_1007_s10384_018_00645_4 crossref_primary_10_2220_biomedres_34_215 crossref_primary_10_3928_1081_597X_20070301_13 crossref_primary_10_1021_la1051172 crossref_primary_10_1111_j_1600_0668_2006_00429_x crossref_primary_10_1016_j_clae_2022_101809 crossref_primary_10_1016_j_jtos_2019_02_010 crossref_primary_10_1016_S1542_0124_12_70167_2 crossref_primary_10_1093_imammb_dqx021 crossref_primary_10_1167_iovs_62_9_13 crossref_primary_10_1016_j_clae_2017_03_001 crossref_primary_10_1070_QEL17213 crossref_primary_10_1016_S1542_0124_12_70157_X crossref_primary_10_1097_IIO_0b013e31822d6af1 crossref_primary_10_1016_j_jtos_2017_03_006 crossref_primary_10_1016_j_survophthal_2021_04_009 crossref_primary_10_1016_j_clae_2024_102129 crossref_primary_10_1136_oem_2004_016030 crossref_primary_10_3892_etm_2017_4364 crossref_primary_10_1111_opo_13373 crossref_primary_10_1016_j_clae_2005_12_006 crossref_primary_10_1016_j_colsurfb_2020_111392 crossref_primary_10_1007_s10762_018_0497_z crossref_primary_10_1038_eye_2000_156 crossref_primary_10_1016_j_jfo_2022_03_004 crossref_primary_10_1097_OPX_0000000000000420 crossref_primary_10_1097_OPX_0b013e31821cc683 crossref_primary_10_1016_j_jtos_2021_05_009 crossref_primary_10_1097_ICO_0b013e31821b71e6 crossref_primary_10_3341_jkos_2017_58_7_788 crossref_primary_10_1016_j_clae_2018_11_002 crossref_primary_10_1016_S0181_5512_07_89605_7 crossref_primary_10_1016_j_clae_2019_02_001 crossref_primary_10_1016_j_colsurfb_2005_05_011 crossref_primary_10_3390_pharmaceutics14071493 crossref_primary_10_1016_j_jfo_2018_12_001 crossref_primary_10_1016_j_jtos_2016_06_002 crossref_primary_10_1038_sj_eye_6701611 |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS |
Copyright_xml | – notice: 1997 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 P64 7X8 |
DOI | 10.1097/00006324-199701000-00014 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 13 |
ExternalDocumentID | 9148269 2613866 10_1097_00006324_199701000_00014 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -~X .GJ .Z2 0R~ 123 4Q1 4Q2 4Q3 53G 5VS 71W AAAAV AAHPQ AAIQE AAMTA AARTV AASCR AAWTL AAYXX ABASU ABBUW ABDIG ABDPE ABJNI ABPXF ABVCZ ABXRP ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACNCT ACWDW ACWRI ACXJB ACXNZ ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AHQNM AHRYX AHVBC AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BQLVK BS7 C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X EBS EEVPB EJD EX3 F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ JF9 JG8 JK3 JK8 K8S KD2 L-C N~M O9- OAG OAH OCUKA ODA OK1 OLG OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P P6G R58 RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M WH7 WOQ WOW X3V X3W XOL XXN XYM YFH ZB8 ZFV ZXP ZZMQN IQODW AWKKM CGR CUY CVF ECM EIF NPM OLW 7QO 8FD FR3 P64 7X8 |
ID | FETCH-LOGICAL-c436t-a57e54bb67e7847fe2418d89fbb751d211c789d7f27d49ea3730a0461a9d739f3 |
ISSN | 1040-5488 |
IngestDate | Thu Jul 10 23:11:14 EDT 2025 Fri Jul 11 00:24:32 EDT 2025 Wed Feb 19 02:36:04 EST 2025 Fri May 23 02:31:14 EDT 2025 Tue Jul 01 01:35:31 EDT 2025 Thu Apr 24 22:56:53 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Tear film Human Visual system Stability Tear Lipids Physiology Evaporation |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c436t-a57e54bb67e7847fe2418d89fbb751d211c789d7f27d49ea3730a0461a9d739f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 9148269 |
PQID | 16007726 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_78880765 proquest_miscellaneous_16007726 pubmed_primary_9148269 pascalfrancis_primary_2613866 crossref_primary_10_1097_00006324_199701000_00014 crossref_citationtrail_10_1097_00006324_199701000_00014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1997-01-00 1997 1997-Jan 19970101 |
PublicationDateYYYYMMDD | 1997-01-01 |
PublicationDate_xml | – month: 01 year: 1997 text: 1997-01-00 |
PublicationDecade | 1990 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Optometry and vision science |
PublicationTitleAlternate | Optom Vis Sci |
PublicationYear | 1997 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
SSID | ssj0017356 |
Score | 2.007872 |
Snippet | Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has suggested... Purpose. Previous work on rabbits has demonstrated a four-fold increase in tear evaporation when the tear lipid layer is removed. However, in vitro work has... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 8 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Eye and associated structures. Visual pathways and centers. Vision Female Fundamental and applied biological sciences. Psychology Humans Lacrimal Apparatus - physiology Lipids - physiology Male Middle Aged Tears - physiology Vertebrates: nervous system and sense organs Volatilization |
Title | Importance of the Lipid Layer in Human Tear Film Stability and Evaporation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9148269 https://www.proquest.com/docview/16007726 https://www.proquest.com/docview/78880765 |
Volume | 74 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZB2Mwxr5K062bHvZWXGJLlqzHsg-arElgS6FvRrZkCCSOaZ099K_f6SOKs2VbtxcTjGUH3U-nu9Pd7xB6TxKiwJMQEZeKRTQrVCTjkkZMJjFLSaG0ra0aT9jFFR1dp9e93mUna2ndFmfl3d66kv-RKtwDuZoq2X-QbHgp3IDfIF-4goThei8ZD5fWejZr0x_1L-bNXJ0uJBjSJpLhOvCZlF1DwLQ0gQObDOtIl_R32XgEdG3UadOulrq9cQ-54vNTv1OGI4uv50Nb7DQ621aIzabjy-Hk23SyjZEqX2DHt5GEPYwQNpIwX5h0nY6SNFmI4OlkXS3qeu3soMWpxKyzt7qy01-0tmMDtlsn2Hc292UQ-5J3V2K6S5T90wYW0grBGyQZYw_QwwScBqOmPw6_hDMlTmwv3_DvfV7XhsJz36d3jJUnjbyFdVO5hie_90isZTJ7hp56lwKfO3w8Rz1dv0CPxj5p4iUabWGCVxUGmGALE2xhguc1tjDBBibYwAQHmGBAAO7A5BW6-vxp9uEi8i00opIS1kYy5TqlRcG45mCHVBoMtkxloioKnsawSuOSZ0LxKuGKCi0JKHxpOPgl3CSiIofooF7V-gjhgkohdJXIkg-ookxUpWFRUAPNlcxU1Ud8M1d56fnlTZuTRd7Jc7CznIdZtqkPtI_iMLJxHCv3GHOyI44w0GOgj95txJODwjSnYLLWq_VtHpuODDz5wxMmKjTgLO2jQyfX8HJhWHOZOP7Lx1-jx47l2ETq3qCD9matT8B2bYu3FpI_AC2jk0w |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+the+lipid+layer+in+human+tear+film+stability+and+evaporation&rft.jtitle=Optometry+and+vision+science&rft.au=CRAIG%2C+J.+P&rft.au=TOMLINSON%2C+A&rft.date=1997&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=1040-5488&rft.volume=74&rft.issue=1&rft.spage=8&rft.epage=13&rft_id=info:doi/10.1097%2F00006324-199701000-00014&rft.externalDBID=n%2Fa&rft.externalDocID=2613866 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-5488&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-5488&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-5488&client=summon |